Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

  • Unknown sort schema '{last_sort_schema}' ignored
  • The following term was not found in PubMed: BG%5BAuthor%5D.
1.

Dual-Sized Microparticle System for Generating Suppressive Dendritic Cells Prevents and Reverses Type 1 Diabetes in the Nonobese Diabetic Mouse Model.

Lewis JS, Stewart JM, Marshall GP, Carstens MR, Zhang Y, Dolgova NV, Xia C, Brusko TM, Wasserfall CH, Clare-Salzler MJ, Atkinson MA, Keselowsky BG.

ACS Biomater Sci Eng. 2019 May 13;5(5):2631-2646. doi: 10.1021/acsbiomaterials.9b00332. Epub 2019 Mar 26.

2.

Locally anchoring enzymes to tissues via extracellular glycan recognition.

Farhadi SA, Bracho-Sanchez E, Fettis MM, Seroski DT, Freeman SL, Restuccia A, Keselowsky BG, Hudalla GA.

Nat Commun. 2018 Nov 22;9(1):4943. doi: 10.1038/s41467-018-07129-6.

3.

Poly(2-propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles as a targeted antigen delivery system to direct either CD4+ or CD8+ T cell activation.

Yang L, Bracho-Sanchez E, Fernando LP, Lewis JS, Carstens MR, Duvall CL, Keselowsky BG.

Bioeng Transl Med. 2017 Jul 11;2(2):202-211. doi: 10.1002/btm2.10068. eCollection 2017 Jun.

4.

Enzymes as Immunotherapeutics.

Farhadi SA, Bracho-Sanchez E, Freeman SL, Keselowsky BG, Hudalla GA.

Bioconjug Chem. 2018 Mar 21;29(3):649-656. doi: 10.1021/acs.bioconjchem.7b00719. Epub 2018 Jan 31. Review.

5.

Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.

Fernando LP, Lewis JS, Evans BC, Duvall CL, Keselowsky BG.

J Biomed Mater Res A. 2018 Apr;106(4):1022-1033. doi: 10.1002/jbm.a.36298. Epub 2017 Dec 21.

6.

An antigen-specific semi-therapeutic treatment with local delivery of tolerogenic factors through a dual-sized microparticle system blocks experimental autoimmune encephalomyelitis.

Cho JJ, Stewart JM, Drashansky TT, Brusko MA, Zuniga AN, Lorentsen KJ, Keselowsky BG, Avram D.

Biomaterials. 2017 Oct;143:79-92. doi: 10.1016/j.biomaterials.2017.07.029. Epub 2017 Jul 24.

7.

Combinatorial drug delivery approaches for immunomodulation.

Stewart JM, Keselowsky BG.

Adv Drug Deliv Rev. 2017 May 15;114:161-174. doi: 10.1016/j.addr.2017.05.013. Epub 2017 May 19. Review.

8.

Dendritic cells in the host response to implanted materials.

Keselowsky BG, Lewis JS.

Semin Immunol. 2017 Feb;29:33-40. doi: 10.1016/j.smim.2017.04.002. Epub 2017 May 7. Review.

9.

Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis.

Zaveri TD, Dolgova NV, Lewis JS, Hamaker K, Clare-Salzler MJ, Keselowsky BG.

Biomaterials. 2017 Jan;115:128-140. doi: 10.1016/j.biomaterials.2016.10.038. Epub 2016 Oct 27.

10.

Micro and Nano Material Carriers for Immunomodulation.

Bracho-Sanchez E, Xia CQ, Clare-Salzler MJ, Keselowsky BG.

Am J Transplant. 2016 Dec;16(12):3362-3370. doi: 10.1111/ajt.13878. Epub 2016 Jun 27. Review.

11.

A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.

Acharya AP, Carstens MR, Lewis JS, Dolgova N, Xia CQ, Clare-Salzler MJ, Keselowsky BG.

J Mater Chem B. 2016 Mar 7;4(9):1672-1685. Epub 2015 Sep 30.

12.

A combination hydrogel microparticle-based vaccine prevents type 1 diabetes in non-obese diabetic mice.

Yoon YM, Lewis JS, Carstens MR, Campbell-Thompson M, Wasserfall CH, Atkinson MA, Keselowsky BG.

Sci Rep. 2015 Aug 17;5:13155. doi: 10.1038/srep13155.

13.

Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.

Carstens MR, Fisher RC, Acharya AP, Butterworth EA, Scott E, Huang EH, Keselowsky BG.

Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8732-7. doi: 10.1073/pnas.1505374112. Epub 2015 Jun 29.

14.

A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Lewis JS, Dolgova NV, Zhang Y, Xia CQ, Wasserfall CH, Atkinson MA, Clare-Salzler MJ, Keselowsky BG.

Clin Immunol. 2015 Sep;160(1):90-102. doi: 10.1016/j.clim.2015.03.023. Epub 2015 Apr 2.

15.

VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.

Han C, Choe SW, Kim YH, Acharya AP, Keselowsky BG, Sorg BS, Lee YJ, Oh SP.

Angiogenesis. 2014 Oct;17(4):823-830. doi: 10.1007/s10456-014-9436-3. Epub 2014 Jun 24.

16.

Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.

Lewis JS, Roche C, Zhang Y, Brusko TM, Wasserfall CH, Atkinson M, Clare-Salzler MJ, Keselowsky BG.

J Mater Chem B. 2014 May 7;2(17):2562-2574.

17.

Integrin-directed modulation of macrophage responses to biomaterials.

Zaveri TD, Lewis JS, Dolgova NV, Clare-Salzler MJ, Keselowsky BG.

Biomaterials. 2014 Apr;35(11):3504-15. doi: 10.1016/j.biomaterials.2014.01.007. Epub 2014 Jan 24.

18.

Materials that harness and modulate the immune system.

Lewis JS, Roy K, Keselowsky BG.

MRS Bull. 2014 Jan 1;39(1):25-34.

19.

The effect of cyclic mechanical strain on activation of dendritic cells cultured on adhesive substrates.

Lewis JS, Dolgova NV, Chancellor TJ, Acharya AP, Karpiak JV, Lele TP, Keselowsky BG.

Biomaterials. 2013 Dec;34(36):9063-70. doi: 10.1016/j.biomaterials.2013.08.021. Epub 2013 Sep 3.

20.

Combinatorial co-encapsulation of hydrophobic molecules in poly(lactide-co-glycolide) microparticles.

Acharya AP, Lewis JS, Keselowsky BG.

Biomaterials. 2013 Apr;34(13):3422-30. doi: 10.1016/j.biomaterials.2013.01.032. Epub 2013 Feb 1.

Supplemental Content

Loading ...
Support Center